Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series.

Guisado-Vasco P, Arranz-Saez R, Canales M, Cánovas A, Garcia-Laraña J, García-Sanz R, Lopez A, López JL, Llanos M, Moraleda JM, Rodriguez J, Rayón C, Sabin P, Salar A, Marín-Niebla A, Morente M, Sánchez-Godoy P, Tomás JF, Muriel A, Abraira V, Piris MA, Garcia JF, Montalban C; Spanish Hodgkin Lymphoma Study Group.

Leuk Lymphoma. 2012 May;53(5):812-9. doi: 10.3109/10428194.2011.635861. Epub 2012 Jan 31.

PMID:
22185637
[PubMed - indexed for MEDLINE]
2.

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.

Barragán E, Montesinos P, Camos M, González M, Calasanz MJ, Román-Gómez J, Gómez-Casares MT, Ayala R, López J, Fuster Ó, Colomer D, Chillón C, Larrayoz MJ, Sánchez-Godoy P, González-Campos J, Manso F, Amador ML, Vellenga E, Lowenberg B, Sanz MA; PETHEMA; HOVON Groups.

Haematologica. 2011 Oct;96(10):1470-7. doi: 10.3324/haematol.2011.044933. Epub 2011 Jun 17.

PMID:
21685470
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.

Montesinos P, Rayón C, Vellenga E, Brunet S, González J, González M, Holowiecka A, Esteve J, Bergua J, González JD, Rivas C, Tormo M, Rubio V, Bueno J, Manso F, Milone G, de la Serna J, Pérez I, Pérez-Encinas M, Krsnik I, Ribera JM, Escoda L, Lowenberg B, Sanz MA; PETHEMA; HOVON Groups.

Blood. 2011 Feb 10;117(6):1799-805. doi: 10.1182/blood-2010-04-277434. Epub 2010 Dec 8.

PMID:
21148082
[PubMed - indexed for MEDLINE]
Free Article
4.

Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.

Lahuerta JJ, Mateos MV, Martínez-López J, Grande C, de la Rubia J, Rosiñol L, Sureda A, García-Laraña J, Díaz-Mediavilla J, Hernández-García MT, Carrera D, Besalduch J, de Arriba F, Oriol A, Escoda L, García-Frade J, Rivas-González C, Alegre A, Bladé J, San Miguel JF; Grupo Español de MM and Programa para el Estudio de la Terapéutica en Hemopatía Maligna Cooperative Study Groups.

Haematologica. 2010 Nov;95(11):1913-20. doi: 10.3324/haematol.2010.028027. Epub 2010 Jul 27.

PMID:
20663944
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases.

Calvo-Villas JM, Fernández JA, de la Fuente I, Godoy AC, Mateos MC, Poderós C.

Br J Haematol. 2010 Sep;150(5):618-20. doi: 10.1111/j.1365-2141.2010.08238.x. Epub 2010 May 13. No abstract available.

PMID:
20487439
[PubMed - indexed for MEDLINE]
6.

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

Sanz MA, Montesinos P, Rayón C, Holowiecka A, de la Serna J, Milone G, de Lisa E, Brunet S, Rubio V, Ribera JM, Rivas C, Krsnik I, Bergua J, González J, Díaz-Mediavilla J, Rojas R, Manso F, Ossenkoppele G, González JD, Lowenberg B; PETHEMA and HOVON Groups.

Blood. 2010 Jun 24;115(25):5137-46. doi: 10.1182/blood-2010-01-266007. Epub 2010 Apr 14.

PMID:
20393132
[PubMed - indexed for MEDLINE]
Free Article
7.

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.

Oriol A, Vives S, Hernández-Rivas JM, Tormo M, Heras I, Rivas C, Bethencourt C, Moscardó F, Bueno J, Grande C, del Potro E, Guardia R, Brunet S, Bergua J, Bernal T, Moreno MJ, Calvo C, Bastida P, Feliu E, Ribera JM; Programa Español de Tratamiento en Hematologia Group.

Haematologica. 2010 Apr;95(4):589-96. doi: 10.3324/haematol.2009.014274. Epub 2010 Feb 9.

PMID:
20145276
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.

Paiva B, Vidriales MB, Mateo G, Pérez JJ, Montalbán MA, Sureda A, Montejano L, Gutiérrez NC, García de Coca A, de las Heras N, Mateos MV, López-Berges MC, García-Boyero R, Galende J, Hernández J, Palomera L, Carrera D, Martínez R, de la Rubia J, Martín A, González Y, Bladé J, Lahuerta JJ, Orfao A, San-Miguel JF; GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Groups.

Blood. 2009 Nov 12;114(20):4369-72. doi: 10.1182/blood-2009-05-221689. Epub 2009 Sep 15.

PMID:
19755674
[PubMed - indexed for MEDLINE]
Free Article
9.

A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples.

Sánchez-Espiridión B, Sánchez-Aguilera A, Montalbán C, Martin C, Martinez R, González-Carrero J, Poderos C, Bellas C, Fresno MF, Morante C, Mestre MJ, Mendez M, Mazorra F, Conde E, Castaño A, Sánchez-Godoy P, Tomas JF, Morente MM, Piris MA, García JF; Spanish Hodgkin's Lymphoma Study Group.

Clin Cancer Res. 2009 Feb 15;15(4):1367-75. doi: 10.1158/1078-0432.CCR-08-1119.

PMID:
19228737
[PubMed - indexed for MEDLINE]
Free Article
10.

Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.

Quijano S, López A, Manuel Sancho J, Panizo C, Debén G, Castilla C, Antonio García-Vela J, Salar A, Alonso-Vence N, González-Barca E, Peñalver FJ, Plaza-Villa J, Morado M, García-Marco J, Arias J, Briones J, Ferrer S, Capote J, Nicolás C, Orfao A; Spanish Group for the Study of CNS Disease in NHL.

J Clin Oncol. 2009 Mar 20;27(9):1462-9. doi: 10.1200/JCO.2008.17.7089. Epub 2009 Feb 17.

PMID:
19224854
[PubMed - indexed for MEDLINE]
Free Article
11.

Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.

Carreras E, Rosiñol L, Terol MJ, Alegre A, de Arriba F, García-Laraña J, Bello JL, García R, León A, Martínez R, Peñarrubia MJ, Poderós C, Ribas P, Ribera JM, San Miguel J, Bladé J, Lahuerta JJ; Spanish Myeloma Group/PETHEMA.

Biol Blood Marrow Transplant. 2007 Dec;13(12):1448-54.

PMID:
18022574
[PubMed - indexed for MEDLINE]
12.

Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.

Ribera JM, Ortega JJ, Oriol A, Bastida P, Calvo C, Pérez-Hurtado JM, González-Valentín ME, Martín-Reina V, Molinés A, Ortega-Rivas F, Moreno MJ, Rivas C, Egurbide I, Heras I, Poderós C, Martínez-Revuelta E, Guinea JM, del Potro E, Deben G.

J Clin Oncol. 2007 Jan 1;25(1):16-24.

PMID:
17194902
[PubMed - indexed for MEDLINE]
Free Article
13.

[Peritoneal tuberculosis in a patient with chronic lymphatic leukemia in treatment with fludarabine].

Albo C, Benítez E, Constenla MI, Plaza J, Poderós C.

Sangre (Barc). 1996 Apr;41(2):164. Spanish. No abstract available.

PMID:
9045364
[PubMed - indexed for MEDLINE]
14.

[Development of non-Hodgkin's lymphoma in the course of idiopathic myelofibrosis].

Albo C, Solominos de Marcos N, Dios A, Poderós C, Carreró J.

Sangre (Barc). 1994 Apr;39(2):127-8. Spanish.

PMID:
8059291
[PubMed - indexed for MEDLINE]
15.

[Physiopathological heterogeneity of peptic ulcer: approach to the identification of groups of duodenal ulcer patients].

Lanas A, Montoro M, Poderos C, Gomollón F, Sainz R.

Rev Esp Enferm Apar Dig. 1985 Aug;68(2):103-9. Spanish. No abstract available.

PMID:
3865268
[PubMed - indexed for MEDLINE]
16.

[Association of Von Recklinghausen syndrome, chronic myeloid leukemia (juvenile variety) and congenital bone abnormalities. Cytochemical study].

Gutíerrez M, Poderós C, Gómez F, Romero MS, Tres A, Larios A, Sarriá A.

Rev Clin Esp. 1984 Feb 29;172(4):233-4. Spanish. No abstract available.

PMID:
6429747
[PubMed - indexed for MEDLINE]
17.

[Myocardial infarction after mediastinal radiotherapy of Hodgkin's disease].

Tres A, Fuertes MA, Callén L, Poderós C, Rodrigo G, Peleato A, Polo J, Gutiérrez M.

Rev Esp Oncol. 1984;31(3):477-82. Spanish.

PMID:
6546176
[PubMed - indexed for MEDLINE]
18.

[Classical factor VII deficiency: biological and genetic evaluation of 3 families].

Ercoreca L, Cornudella R, Lucía JF, Poderoś C, Urquiá A, Tres A, Raichs A, Gutiérrez M.

Sangre (Barc). 1984;29(2):121-32. Spanish. No abstract available.

PMID:
6474306
[PubMed - indexed for MEDLINE]
19.

[Detection of a new case of absence of erythrocyte antigens of the Kell system (Peltz phenotype)].

Gómez Casal F, Poderós C, Soler H, Romero MS, Fuertes MA, Callén L, Tres A, Gutiérrez M.

Med Clin (Barc). 1983 Jan 15;80(1):50-1. Spanish. No abstract available.

PMID:
6834918
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk